Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Press Releases

NovellusDx announced today the completion of the first phase of an in-vitro study to characterize the functional activity of ERK1/2 mutations, and their response to BioMed Valley Discoveries' lead compound BVD523. "The MAPK signaling pathway is canonical and controls cell growth, proliferation, and survival. It has aberrant signaling activity in…

Press Releases

Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that it is adding European study centers to its ongoing Phase II clinical trial evaluating alvocidib in the U.S. and Canada for the treatment of MCL-1-dependent relapsed/refractory acute myeloid leukemia (AML). "Based on our improved understanding…

Press Releases

It has been widely reported in the national press, including US Today, Modern Healthcare, and the New York Times, that there is a nation-wide shortage of pharmaceutical quality sodium bicarbonate available to hospitals. A shortage of the antacid is prompting healthcare providers to carefully prioritize procedures, delay some operations or…

Press Releases

A Summit on the Latest Research and Developments in the Emerging Treatment for Cancer - Immunotherapy. Vonlanthen Group of Companies will be hosting the 2nd Annual Cancer Immunotherapy Summit on September 21st – 22nd, 2017 in Vienna, Austria. Because of the success of the 1st Annual Cancer Immunotherapy Summit and…

Press Releases

Lannett Company, Inc. announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Niacin Extended-Release Tablets USP, 500 mg and 1000 mg, the therapeutic equivalent to the reference listed drug, Niaspan® Extended-Release Tablets, 500 mg and 1000 mg, of…

Press Releases

Tarveda Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing Pentarins™ as a new class of potent and selective cancer medicines, today announced the appointment of Michael A. Metzger to the company’s Board of Directors. Mr. Metzger has more than 20 years of experience leading value-creating corporate development, strategic and…

Press Releases

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical chemists to obtain high-resolution separations with outstanding sensitivity and reproducibility. Visitors can learn about these and other innovations during HPLC 2017 - The 46th International Symposium on High Performance Liquid…

Press Releases

PharmaMar has announced that PM1183 (lurbinectedin), its third molecule of marine origin and analogue of Yondelis®, will receive the trade name of Zepsyre™. Zepsyre™ is currently undergoing development for the treatment of solid tumours. This promising agent is currently in final stage for platinum-resistant ovarian cancer and small cell lung…

Press Releases

The clinical trials and research outsourcing (CRO) market is growing, leveraging the global pharmaceutical industry's urgent need to succeed in late clinical trials and build the pipeline of new molecules. While cost benefits, focus on core competencies, rise in innovative therapeutic options, and increased drug efficacy and safety norms will…

Press Releases

Debiopharm International SA, part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced the completion of enrollment in dose finding and efficacy phase I/II trial Debio 1143-201 for the treatment of locally advanced squamous cell carcinoma of the head and neck. The phase II portion of the study enrolled…

loader